HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identifying the target lesions for 245 laser angioplasty cases and a review of the literature.

AbstractOBJECTIVE:
To provide a detailed report of our experience with laser atherectomy in a large patient population with an extensive follow-up period.
METHOD:
A retrospective chart review was conducted on 222 patients who underwent laser atherectomy.
RESULTS:
Overall primary patency rates at 1 and 3 years were 48% and 37%, primary-assisted rates were 53% and 40%, and secondary patency rates were 69% and 51%, respectively. Limb salvage rates were 91% and 83%. The 1- and 3-year primary patency rates were significantly different between the native (51% and 39%) and the in-stent group (20% and 20%; P = .027). There were no differences in primary-assisted patency (P = .11), secondary patency (P = .094), and limb salvage rates (P= .83) between the 2 groups.
CONCLUSIONS:
Although the primary patency of laser angioplasty was higher in native vessels versus the in-stent stenosis, there were no differences in the primary-assisted patency, secondary patency, or limb salvage rates between the 2 groups.
AuthorsJung H Kim, Sadaf S Ahanchi, Jean M Panneton
JournalVascular and endovascular surgery (Vasc Endovascular Surg) Vol. 46 Issue 8 Pg. 640-7 (Nov 2012) ISSN: 1938-9116 [Electronic] United States
PMID23129583 (Publication Type: Comparative Study, Journal Article, Review)
Topics
  • Aged
  • Aged, 80 and over
  • Angioplasty, Laser (adverse effects)
  • Atherectomy (adverse effects)
  • Chi-Square Distribution
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Limb Salvage
  • Lower Extremity (blood supply)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Peripheral Arterial Disease (diagnosis, therapy)
  • Proportional Hazards Models
  • Recurrence
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Vascular Patency

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: